Improving mesothelioma therapy by boosting immune responses to mutations by vaccination and by immunogenic chemotherapy

Project Details

StatusActive
Effective start/end date1/04/2030/06/23

Funding

  • US Department of Defense: A$225,107.00
  • US Department of Defense: A$482,030.00
  • US Department of Defense: A$504,661.00
  • US Department of Defense: A$244,268.00